Inflammatory Myofibroblastic Tumor of the Tongue. Report of a Pediatric Case and Review of the Literature

References

• Coffin CM, Hornick L, Fletcher CDM.. Inflammatory myofibroblastic tumor. In: Fletcher C. D. M, Unni K. K., Mertens F., editor(s). Pathology and Genetics of Tumors of Soft Tissue and Bone, vol 5, Lyon, France: IARC Press; 2002. pp 91–93.
   Google Scholar
• Lourenço SV, Boggio P, Simonsen Nico MM. Inflammatory myofibroblastic tumor of the tongue: report of an unusual case in a teenage patient. Dermatol Online J. 2014;18(5):6.
   PubMedGoogle Scholar
• Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995;19(8):859–72. doi:10.1097/00000478-199508000-00001. PMID:7611533.
   PubMed Web of Science ®Google Scholar
• Buccoliero AM, Ghionzoli M, Castiglione F, Paglierani M, Baroni G, Messineo A, Taddei GL. Inflammatory myofibroblastic tumor: clinical, morphological, immunohistochemical and molecular features of a pediatric case. Pathol Res Pract. 2014;210(12):1152–5. doi:10.1016/j.prp.2014.03.011. PMID:25149504.
   PubMed Web of Science ®Google Scholar
• Brooks JK, Nikitakis NG, Frankel BF, Papadimitriou JC, Sauk JJ. Oral inflammatory myofibroblastic tumor demonstrating ALK, p53, MDM2, CDK4, pRb, and Ki-67 immunoreactivity in an elderly patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99(6):716–26. doi:10.1016/j.tripleo.2004.11.023. PMID:15897859.
   PubMed Web of Science ®Google Scholar
• Ide F, Shimoyama T, Horie N. Sclerosing inflammatory myofibroblastic tumour of the tongue: an immunohistochemical and ultrastructural study. Oral Oncol. 2000;36(3):300–4. doi:10.1016/S1368-8375(99)00091-3. PMID:10793334.
   PubMed Web of Science ®Google Scholar
• Pankaj C, Uma C. How to manage oral inflammatory myofibroblastic tumor (inflammatory pseudotumor)? Oral Dis. 2001;7(5):315–6. doi:10.1034/j.1601-0825.2001.00696.x. PMID:12117208.
   PubMed Web of Science ®Google Scholar
• Gleizal A, Ranchere-Vince C, Beziat JL. Inflammatory myofibroblastic tumour of the tongue: a case report. Br J Oral Maxillofac Surg. 2007;45(5):423–4. doi:10.1016/j.bjoms.2006.01.005. PMID:16510218.
   PubMed Web of Science ®Google Scholar
• Yucel Ekici N, Bayindir T, Kizilay A, Aydin NE. Inflammatory myofibroblastic tumor: a rare tumor in the tongue. Case Rep Otolaryngol. 2013;2013:787–824.
   Google Scholar
• Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31(4):509–20. doi:10.1097/01.pas.0000213393.57322.c7. PMID:17414097.
   PubMed Web of Science ®Google Scholar
• Palaskar S, Koshti S, Maralingannavar M, Bartake A. Inflammatory myofibroblastic tumor. Contemp Clin Dent. 2011;2(4):274–7. doi:10.4103/0976-237X.91787. PMID:22346151.
   PubMedGoogle Scholar
• Saab ST, Hornick JL, Fletcher CD, Olson SJ, Coffin CM. IgG4 plasma cells in inflammatory myofibroblastic tumor: inflammatory marker or pathogenic link? Mod Pathol. 2011;24(4):606–12. doi:10.1038/modpathol.2010.226. PMID:21297584.
   PubMed Web of Science ®Google Scholar
• Bridge JA, Kanamori M, Ma Z, Pickering D, Hill DA, Lydiatt W, Lui MY, Colleoni GW, Antonescu CR, Ladanyi M, et al. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol. 2001;159(2):411–5. doi:10.1016/S0002-9440(10)61711-7. PMID:11485898.
   PubMed Web of Science ®Google Scholar
• Corao DA, Biegel JA, Coffin CM, Barr FG, Wainwright LM, Ernst LM, Choi JK, Zhang PJ, Pawel BR. ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status. Pediatr Dev Pathol. 2009;12(4):275–83. doi:10.2350/08-03-0434.1. PMID:18788887.
   PubMed Web of Science ®Google Scholar
• Minoo P, Wang HY. ALK-immunoreactive neoplasms. Int J Clin Exp Pathol. 2012;5(5):397–410. PMID:22808292.
   PubMed Web of Science ®Google Scholar
• Chun YS, Wang L, Nascimento AG, Moir CR, Rodeberg DA. Pediatric inflammatory myofibroblastic tumor: anaplastic lymphoma kinase (ALK) expression and prognosis. Pediatr Blood Cancer. 2005;45(6):796–801. doi:10.1002/pbc.20294. PMID:15602716.
   PubMed Web of Science ®Google Scholar
• Jiang YH, Cheng B, Ge MH, Cheng Y, Zhang G. Comparison of the clinical and immunohistochemical features, including anaplastic lymphoma kinase (ALK) and p53, in inflammatory myofibroblastic tumours. J Int Med Res. 2009;37(3):867–77. doi:10.1177/147323000903700332. PMID:19589272.
   PubMed Web of Science ®Google Scholar
• Sukov WR, Cheville JC, Carlson AW, Shearer BM, Piatigorsky EJ, Grogg KL, Sebo TJ, Sinnwell JP, Ketterling RP. Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder. Mod Pathol. 2007;20(5):592–603. doi:10.1038/modpathol.3800776. PMID:17396140.
   PubMed Web of Science ®Google Scholar
• Lovly CM, Gupta A, Lipson D, Otto G, Brennan T, Chung CT, Borinstein SC, Ross JS, Stephens PJ, Miller VA, et al. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. Cancer Discov. 2014;4(8):889–95. doi:10.1158/2159-8290.CD-14-0377. PMID:24875859.
   PubMed Web of Science ®Google Scholar
• Alassiri AH, Ali RH, Shen Y, Lum A, Strahlendorf C, Deyell R, Rassekh R, Sorensen PH, Laskin J, Marra M, et al. ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors. Am J Surg Pathol. 2016;40(8):1051–61. doi:10.1097/PAS.0000000000000677. PMID:27259007.
   PubMed Web of Science ®Google Scholar
• Swain RS, Tihan T, Horvai AE, Di Vizio D, Loda M, Burger PC, Scheithauer BW, Kim GE. Inflammatory myofibroblastic tumor of the central nervous system and its relationship to inflammatory pseudotumor. Hum Pathol. 2008;39(3):410–9. doi:10.1016/j.humpath.2007.07.012. PMID:18261625.
   PubMed Web of Science ®Google Scholar
• Butrynski JE, D'Adamo DR, Hornick JL, Dal Cin P, Antonescu CR, Jhanwar SC, Ladanyi M, Capelletti M, Rodig SJ, Ramaiya N, et al. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med. 2010;363(18):1727–33. doi:10.1056/NEJMoa1007056. PMID:20979472.
   PubMed Web of Science ®Google Scholar
• Tothova Z, Wagner AJ. Anaplastic lymphoma kinase-directed therapy in inflammatory myofibroblastic tumors. Curr Opin Oncol. 2012;24(4):409–13. doi:10.1097/CCO.0b013e328354c155. PMID:22664824.
   PubMed Web of Science ®Google Scholar
• Chennouf A, Arslanian E, Roberge D, Berthelet F, Bojanowski M, Bahary JP, Masucci L, Belanger K, Florescu M, Wong P. Efficiency of Crizotinib on an ALK-Positive Inflammatory Myofibroblastic Tumor of the Central Nervous System: A Case Report. Cureus. 2017;9(3):e1068. PMID:28409069.
   PubMedGoogle Scholar